Submit Deal
All Dealmakers
Similar Dealmakers
CEO at FORESITE CAPITAL MANAGEMENT LLC
Investor
Share Profile
Deal Bio
Market Context
Back to top
All rights reserved. Copyright © 2026 Datasite
Expertise (32)
Key Relationships
Sort
Target: INSITRO
Bidder: ALEXANDRIA VENTURE INVESTMENTS
16 Service Providers
38 Dealmakers
£ 116 M
Value
Target: KINNATE BIOPHARMA
Bidder: NEXTECH INVEST
9 Service Providers
9 Dealmakers
£ 74 M
Target: VELOSBIO INC
Bidder: CORMORANT ASSET MANAGEMENT
14 Service Providers
16 Dealmakers
£ 105 M
Target: GEMINI THERAPEUTICS
Bidder: FS DEVELOPMENT CORP
13 Service Providers
45 Dealmakers
£ 166 M
Bidder: MERCK & CO INC
17 Service Providers
55 Dealmakers
£ 2.12 B
Target: NURIX THERAPEUTICS
Bidder: BAIN CAPITAL LIFE SCIENCES
7 Service Providers
10 Dealmakers
£ 95 M
Target: QUANTUM-SI
Bidder: HIGHCAPE CAPITAL ACQUISITION CORP
37 Dealmakers
£ 1.05 B
Bidder: BLACKROCK
27 Dealmakers
£ 287 M
Target: SOMALOGIC
Bidder: JANUS HENDERSON INVESTORS
22 Service Providers
63 Dealmakers
£ 891 M
Target: GENOMICS PLC
Bidder: OXFORD SCIENCES INNOVATION
14 Dealmakers
£ 21 M
Target: INSCRIPTA INC
Bidder: FORESITE CAPITAL MANAGEMENT LLC
8 Service Providers
8 Dealmakers
£ 108 M
Target: CROSSOVER HEALTH
Bidder: PERCEPTIVE ADVISORS LLC
11 Service Providers
18 Dealmakers
£ 121 M
Target: GENERATION BIO INC
Bidder: WELLINGTON MANAGEMENT
12 Dealmakers
£ 83 M
Target: TANGO THERAPEUTICS
29 Service Providers
32 Dealmakers
£ 257 M
Target: EIKON THERAPEUTICS INC
Bidder: THE COLUMN GROUP
5 Service Providers
6 Dealmakers
£ 106 M
Target: HEALTHVERITY
Bidder: DURABLE CAPITAL PARTNERS
£ 71 M
Target: ELEMENT BIOSCIENCES
Bidder: COUNTERPOINT GLOBAL - MORGAN STANLEY
£ 198 M
Target: PARDES BIOSCIENCES
Bidder: ECOR1 CAPITAL
£ 199 M
Target: KRIYA THERAPEUTICS INC
Bidder: WOODLINE PARTNERS
£ 72 M
Target: MAMMOTH BIOSCIENCES
Bidder: GREENSPRING ASSOCIATES INC
10 Service Providers
Target: BIT.BIO
Bidder: CHARLES RIVER LABORATORIES INTERNATIONAL INC
£ 76 M
Bidder: HAREL GROUP
19 Service Providers
21 Dealmakers
£ 382 M
Target: MAZE THERAPEUTICS
Bidder: DRIEHAUS CAPITAL
£ 139 M
Target: DNANEXUS
Bidder: NORTHPOND VENTURES
30 Dealmakers
£ 151 M
Bidder: NARYA CAPITAL
13 Dealmakers
£ 220 M
Target: IMMPACT BIO
6 Service Providers
£ 81 M
Target: ODYSSEY THERAPEUTICS
Bidder: SVB FINANCIAL GROUP
£ 152 M
Target: ALUMIS
5 Dealmakers
£ 204 M
Target: THIRD ARC BIO
Bidder: VIDA VENTURES
15 Dealmakers
£ 127 M
£ 216 M
Target: AVENZO THERAPEUTICS
Bidder: LILLY ASIA VENTURES
£ 44 M
Target: AEOVIAN PHARMACEUTICALS INC
Bidder: SYMBIOSIS CAPITAL MANAGEMENT LLC
12 Service Providers
£ 41 M
